Please use this identifier to cite or link to this item:
Title: Use of artificial cells as drug carriers
Authors: Emir Diltemiz, Sibel
Tavafoghi, Maryam
de Barros, Natan Roberto
Kanada, Masamitsu
Heinamaki, Jyrki
Contag, Christopher
Ashammakhi, Nureddin
Issue Date: 2021
Publisher: Royal Soc Chemistry
Abstract: Cells are the fundamental functional units of biological systems and mimicking their size, function and complexity is a primary goal in the development of new therapeutic strategies. Recent advances in chemistry, synthetic biology and material science have enabled the development of cell membrane-based drug delivery systems (DDSs), often referred to as artificial cells or protocells. Artificial cells can be made by removing functions from natural systems in a top-down manner, or assembly from synthetic, organic or inorganic materials, through a bottom-up approach where simple units are integrated to form more complex structures. This review covers the latest advances in the development of artificial cells as DDSs, highlighting how their designs have been inspired by natural cells or cell membranes. Advancement of artificial cell technologies has led to a set of drug carriers with effective and controlled release of a variety of therapeutics for a range of diseases, and with increasing complexity they will have a greater impact on therapeutic designs.
ISSN: 2052-1537
Appears in Collections:Makine Mühendisliği Bölümü Koleksiyonu
Scopus İndeksli Yayınlar Koleksiyonu
WoS İndeksli Yayınlar Koleksiyonu

Show full item record

CORE Recommender


checked on Jun 22, 2022

Page view(s)

checked on Oct 3, 2022

Google ScholarTM



Items in GCRIS Repository are protected by copyright, with all rights reserved, unless otherwise indicated.